4.6 Article

Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial

Michel Azizi et al.

Summary: Two studies showed that ultrasound renal denervation can reduce blood pressure in patients with mild to moderate hypertension and treatment-resistant hypertension. This study aimed to investigate the efficacy and safety of ultrasound renal denervation without the influence of antihypertensive medications. The results of a randomized clinical trial demonstrated that ultrasound renal denervation can significantly reduce daytime ambulatory systolic blood pressure in hypertensive patients at 2 months.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Article Peripheral Vascular Disease

Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial

Kazuomi Kario et al.

Summary: This study found no significant difference in ambulatory blood pressure reductions between renal denervation and a sham procedure in treated patients with resistant hypertension. Although the blood pressure reduction after renal denervation was similar to other sham-controlled studies, the unexpected greater reduction in the sham control group in this study highlights design issues that will be addressed in a new trial.

HYPERTENSION RESEARCH (2022)

Article Cardiac & Cardiovascular Systems

Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium

David E. Kandzari et al.

Summary: The clinical implications of hypertension drive the development of device-based therapies. The HARC document integrates expert consensus and regulatory perspectives to address challenges and unmet needs in treating hypertension.

CIRCULATION (2022)

Article Medicine, General & Internal

Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial

Felix Mahfoud et al.

Summary: In this study, the long-term safety and efficacy of renal denervation were evaluated. The results showed that renal denervation produced a clinically meaningful and lasting blood pressure reduction up to 36 months, independent of concomitant antihypertensive medications and without major safety events.

LANCET (2022)

Editorial Material Cardiac & Cardiovascular Systems

What We Know and Don't Know About Renal Denervation to Lower Blood Pressure

Katherine H. Chau et al.

Summary: The article discusses renal denervation as a potential alternative therapy for patients with medication-resistant hypertension.

JAMA CARDIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trial

Florian Rader et al.

Summary: This study assessed the long-term durability of ultrasound RDN in lowering blood pressure. The results showed that over a period of 36 months, patients experienced reduced blood pressure and improved blood pressure control, without any new long-term safety concerns.

EUROINTERVENTION (2022)

Article Medicine, General & Internal

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

Michel Azizi et al.

Summary: Renal denervation through ultrasound treatment shows promising results in reducing blood pressure for patients with resistant hypertension, with greater effectiveness compared to a sham procedure within 2 months and similar safety outcomes. This may provide an alternative approach for patients with resistant hypertension to avoid adding more antihypertensive medications.

LANCET (2021)

Article Cardiac & Cardiovascular Systems

Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension

Michael Boehm et al.

Summary: This analysis evaluated the impact of baseline heart rate on blood pressure reduction after renal denervation. The results showed a greater reduction in blood pressure at 3 months post renal denervation for patients with baseline heart rate >= 70 beats/min.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Article Medicine, General & Internal

Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018

Paul Muntner et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Cardiac & Cardiovascular Systems

12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation

Michel Azizi et al.

JACC-CARDIOVASCULAR INTERVENTIONS (2020)

Article Psychiatry

How to perform a meta-analysis with R: a practical tutorial

Sara Balduzzi et al.

EVIDENCE-BASED MENTAL HEALTH (2019)

Editorial Material Peripheral Vascular Disease

Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right

Michael A. Weber et al.

JOURNAL OF CLINICAL HYPERTENSION (2015)

Article Peripheral Vascular Disease

Renal denervation therapy for hypertension: pathways for moving development forward

William B. White et al.

JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2015)

Editorial Material Cardiac & Cardiovascular Systems

Catheter-Based Renal Denervation Is No Simple Matter Lessons to Be Learned From Our Anatomy?

Felix Mahfoud et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

Article Cardiac & Cardiovascular Systems

Innervation Patterns May Limit Response to Endovascular Renal Denervation

Abraham R. Tzafriri et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

Article Cardiac & Cardiovascular Systems

Anatomic Assessment of Sympathetic Peri-Arterial Renal Nerves in Man

Kenichi Sakakura et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

Article Medicine, General & Internal

A Controlled Trial of Renal Denervation for Resistant Hypertension

Deepak L. Bhatt et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Urology & Nephrology

Orthostatic hypertension-a new haemodynamic cardiovascular risk factor

Kazuomi Kario

NATURE REVIEWS NEPHROLOGY (2013)

Article Computer Science, Interdisciplinary Applications

Conducting Meta-Analyses in R with the metafor Package

Wolfgang Viechtbauer

JOURNAL OF STATISTICAL SOFTWARE (2010)